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Abstract For structure analysis of peptides by multinuclear 
NMR, stable isotope-labeled samples are required, A direct over- 
expression system by E. coli cells does not work for that purpose 
because of rapid degradation of the peptides and/or the mRNA 
in host cells. We here developed an over-expression system by 
means of thioredoxin gene fusion system. The fused protein com- 
posed of thioredoxin and the objective peptide was expressed in 
E. coli and then the peptide part was released by enterokinase. 
This system was successfully applied for the production of ~SN- 
labeled human adrenocorticotropic hormone fragment (ACTH- 
(1-24)) as needed for multinuclear NMR analysis. 
Key words. Human adrenocorticotropic hormone; 
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1. Introduction 
In recent years, the experimental techniques of the multinu- 
clear and multidimensional NMR have drastically progressed. 
The most important role of such experiments is to reduce signal 
degeneracy in higher molecular weight proteins. Although 
there are several advantages ( uch as structure analysis of pep- 
tides complexed with their receptors or receptor fragments, 
heteronuclear chemical shift analysis, or quantitative 3j cou- 
pling constant measurement, etc.) in those experiments besides 
from better signal separation, there are few cases applied to 
peptides o far. This may be the result of the difficulty of stable 
isotope labeling of peptides with 15N and/or ~3C. Because the 
chemical synthesis of labeled peptides is prohibitively expen- 
sive, an over-expression system, in other words, a biosynthesis 
system is required for this purpose. However, an over-expres- 
sion system designed to express the objective peptide directly 
would suffer from the very rapid degradation of the peptides 
and/or the mRNA in host cells such as E. coli. 
We have been interested in the relationship of structure and 
function of human adrenocorticotropic hormone fragment 
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1-24 (ACTH-(1-24))that is a bioactive fragment of the originally 
39 membered peptide and an anterior pituitary origin [1]. Al- 
though we analyzed its solution structure using chemically syn- 
thesized and non-labeled sample, its C-teminal region did not 
converge into a single conformation [2]. In order to have much 
more detailed structure information, we needed stable isotope 
labeled ACTH-(1-24), in other words, a realistic over-expres- 
sion system of ACTH-(1-24) because of reasons described 
above. Then, we constructed an over-expression system to bio- 
synthesize relatively short peptides aimed for heteronuclear 
NMR analysis. In this system, the objective peptide is expressed 
as a fused protein with thioredoxin and released with a se- 
quence specific protease. We here report an application to 
uniform 15N-labeling of ACTH-(1 24) as well as its over-ex- 
pression system. 
2. Materials and methods 
2.1. Construction of ACTH-(1-24) expression vector 
To construct an expression system, two expression vectors, 
pMMPB2 [3] and pTRX-FUS [4] were joined (Fig. 1). The thioredoxin 
gene containing a multicloning site at the 3' end was amplified by PCR 
with the plasmid pTRX-FUS as template with the following two ol- 
igonucleotides as primers containing EagI, Ndel and HindlIl restriction 
enzyme sites, respectively (these sites are underlined in the primer se- 
quence): 
(1) GCCCCCGGCCG CATATGAGCGATAAAATTATTCACC 
(2) GCCCCGAAGCTTCACCCTGTACGATTACTGCAGGTCG 
The PCR product was digested with Eagl and HindllI and ligated 
into the Eagl and HindlII backbone fragment of pMMPB2. To create 
an expression vector pTRF plasmid, the purified plasmid containing 
such fragments was digested with NdeI restriction enzyme and then 
self-ligated. Plasmid pTRX-ACTH was generated by ligating a syn- 
thetic DNA fragment encoding the ACTH-(I-24) amino acid sequence 
(dAGCTACAGTATGGAGCACTTCCGCTGGGGCAAGCCCGT- 
AGGCAAGAAGCGACGACCCGTAAAGGTATACCCCTAGCT - 
GCA/dGCTAGGGGTATACCTTTACGGGTCGTCGCTTCTTGC - 
CTACGGGCTTGCCCCAGCGGAAGTGCTCCATACTGTAGCT ) 
into the KpnI(blunted)-HindlII backbone fragment of pTRX plasmid. 
2.2. Expression and purification of A CTH- (1-24) 
The plasmid pTRX-ACTH was transformed into the host strain 
BL21 (DE3) cell [5]. The transformed cells were grown in 21 YT medium 
at 37°C and then expression was initiated by IPTG (final concentration 
1 mM) when cells had grown to 0.6 OD (620 rim). After 3 h cells were 
harvested and frozen below -20°C. The frozen cell paste was suspended 
in 5 ml lysis buffer (20 mM Tris-HCl, pH 8.0, 2.5 mM EDTA)/1 g wet 
cells followed by sonication for 20 min on ice. Insoluble material was 
removed by centrifugation at 20,000 × g for 30 min at 4°C. The super- 
natant was then loaded onto a HiTrap SP column (Pharmacia Biotech) 
pre-equilibrated with buffer A (20 mM Tris-HC1, pH 8.0, l mM 
EDTA). The protein was eluted with a linear gradient from 50 mM to 
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1 M KCI in buffer A. The fused protein was located in the 0.1 0.2 M 
KCI fraction and dialyzed against distilled water. The purity of the 
isolated protein was analyzed by 20% SDS-PAGE. 
The purified thioredoxin/ACTH-(1-24) fused protein was digested 
overnight with the sequence specific protease, enterokinase (Funako- 
shi) in the digestion buffer (70 mM succinate pH 5.6, 0.5 mM CaC12) 
at 25°C. After digestion, RP-HPLC was used to isolate ACTH-(1 24). 
For this purpose TFA was added to the digested sample (final concen- 
tration of TFA was 0.1%). The solution was loaded onto a C18 column 
(Nakarai) pre-equilibrated with buffer A (90% water, 10% acetonitrile, 
0.1% TFA), and elution was carried out with a linear gradient of buffer 
B (90% acetonitrile, 10% isopropylalchol, 0.1% TFA). 
2.3. N-Terminal analysis and amino acid analysis of the purified 
ACTH-( I~4)  
The N-terminal sequence of the ACTH-(1-24) was determined by the 
Edman degradation method. Amino acid analysis was performed with 
a Hitachi 835-S amino acid analyzer on the acid hydrolysates (6N HC1 
containing 0.2% phenol, ll0°C, 24 h). 
2.4. Expression and purification of uniformly ¢S N-labeled A CTH-(I~4) 
~SN uniformly labeled ACTH-(1 24) was expressed and purified fol- 
lowing the protocols described above with slight modifications: M9 
minimum medium was used instead of YT medium, 2g of tSNH4C1 was 
added to 2.51 medium as 15N source before the cell growth was initiated. 
Upon induction with IPTG cell growth proceeded overnight. After 
RP-HPLC fractions containing ~SN-labeled ACTH-(1 24) were lyophil- 
ized, then dissolved in distilled water, adjusted to pH 6 and lyophilized 
again. 
2.5. NMR experiments 
The ~SN-labeled ACTH-(1-24) was dissolved in aqueous 95% 2,2,2- 
trifluoroethanol-d2 (Isotech's product). 2D-HSQC [6,7,8] experiments 
were carried out on a Bruker's ARX500 spectrometer at 500 MHz for 
proton frequency in the temperature range from 279 K to 288 K. 
Spectral width for the ~H axis was set at 6250 Hz and that of 15N at 330 
Hz, respectively. A GARP pulse sequence was used for 15N decoupling 
during acquisition [9]. 500 ps of spin locking purge pulse was applied 
just before the second IH 90 degree pulse in the HSQC sequence inorder 
to suppress the hydroxyl proton signal from trifluoroethanol [10]. Data 
for HSQC spectrum with 32 (15N) x 512 (IH) in the complex-sized time 
domain were acquired with TPPI-States method [11] for the indirect 
detection of ~SN in order to achieve phase sensitive mode spectra. 
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pTRX-ACTH(1-24) 
Fig. 1. Schematic llustration of the plasmid pTRX-ACTH-(1-24). The 
amino acid sequence of ACTH-(1-24) and the linker sequence which 
is recognized by enterokinase are shown in one letter code. The entero- 
kinase recognition sequence is indicated in bold and the cleavage site 
with an arrow. 
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Fig. 2. (A) Purity of the thioredoxin fused ACTH-(1 24) peptide as 
analyzed by 20% SDS-PAGE; lane 1: lysate of uninduced BL21(DE3) 
containing pTRX-ACTH; lane 2: lysate of induced BL21(DE3) con- 
taining pTRX-ACTH; lane 3: purified thioredoxin fused ACTH-(1 24). 
(B) The results of reverse-phase HPLC as described in section 2. 
ACTH-(1-24) was found in peak 2. 
3. Results 
The expression vector pTRF for the N-terminal fragment 
1 24 of ACTH (Fig. 1) was constructed for an over-expression 
vector by joining two expression vectors, i.e. pMMPB2 which 
contains T7 promoter and pTRX-FUS which contains the 
thioredoxin fused gene so that the thioredoxin gene is con- 
trolled by the T7 polymerase xpression system. Over-produc- 
tion of the thioredoxin/ACTH-(1 24) fused protein was ob- 
tained by adding IPTG (1 mM) to BL21(DE3) cells with the 
plasmid pTRF-ACTH-(1-24) at the mid-logarithmic phase. 
3 h after the induction, the content of the fused protein was 
estimated to be 40% of the total cell protein by SDS-poly- 
acrylamide gel electrophoresis (Fig. 2A). The harvested cells 
were lysed by sonication and the fused protein was detected in 
the soluble fraction. After ion exchange chromatography high 
purity (95%) the thioredoxin/ACTH-(1-24) fused protein was 
isolated in good yield (ca. 10 mg from 1 1 of culture) (Fig. 2A). 
The fused protein was digested with enterokinase, a protease 
which recognizes the amino acid sequence Asp-Asp-Asp-Asp- 
Lys. Then, ACTH-(1-24) was isolated by RP-HPLC (Fig. 2B). 
Peak 1 and peak 2 (Fig. 2B) obtained from this chromatogra- 
phy were analyzed for their N-terminal sequence and amino 
acid composition. The N-terminal sequence analysis indicated 
peak 1 as a mixture of two peptides mixture; one with Trp-Gly- 
Lys-Pro-Val and the other with Ser-Tyr-Ser-Met-Glu at the 
N-termial. On the other hand, the N-terminal sequence of peak 
2 was Ser-Tyr-Ser-Met-Glu. The latter two peptide sequences 
corresponded to the N-terminus of ACTH-(1-24), whereas the 
Trp-Gly-Lys-Pro-Val sequence corresponds to the amino acid 
sequence 9-13 of ACTH-(1 24). To confirm that the peak 2 
peptide is ACTH-(1-24) an amino acid analysis was performed 
(Table 1). In addition, the chemically synthesized ACTH-(1 24) 
(gift of J.W. van Nispen) showed the same retention time as 
peak 2 (data not shown). 
Uniformly lSN-labeled ACTH-(1 24) was obtained along 
with almost the same protocol as decribed above. We obtained 
ca. 6 mg of ]SN-labeled ACTH-(1-24) per 1 1 M9 culture me- 
dium. Fig. 3 shows the region of the cross section in amide 
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Fig. 3. ~SN-~H SQC (heteronuclear single quantum coherence spec- 
troscopy) spectrum of ~SN-labeled ACTH-(1-24) in 95% aqueous 
TFE-d2. 
proton and amide nitrogen of the ~SN-~H SQC spectrum of 
ACTH-(1-24) in 95% aqueous 2,2,2-trifluoroethanol-d2 at 
15°C. 
4. Discussion 
The thioredoxin gene-fused expression system, originally 
constructed by LaVallie [4], bears the main advantage that 
thioredoxin as a periplasm protein, when expressed in E. coli., 
is translocated to the periplasm and accumulated at high con- 
centration. This feature is advantageous for expression of pep- 
tides in E. coli since the thioredoxin-fused system serves to 
prevent digestion by endogenous proteases. In the original ex- 
pression system, the expression of the target protein is con- 
trolled by trp promoter, therefore, tryptophan is needed to 
induce the target protein. However, when a labeled protein is 
needed, the trp promoter is not good choice because the trypto- 
phan has to be added to the medium for the induction. This 
added tryptophan is metabolized by E. coli and taken up into 
the target protein. Therefore as a result, the target protein 
cannot be labeled uniformly by the stable isotopes, 15N or ~3C. 
To overcome this problem, we switched the promoter sequence 
from the trp promoter to the T7 promoter. The T7 promoter 
has the advantage that IPTG is used instead of tryptophan to 
induce the expression of recombinant proteins. 
It is said that the thioredoxin-fused system has the advantage 
of facile purification because thioredoxin is stable to 80°C and 
allows for heating the cell lysate at 80°C for a few minutes. 
Although this heating procedure could be applied in our case, 
it caused almost half the thioredoxin-fused ACTH-(1-24) to 
precipitate into the debris fraction. Therefore, we used conven- 
tional ion chromatography for separation and purification. As 
shown in Fig. 2A, the purity of the thioredoxin-fused ACTH- 
(1-24) was sufficiently high for isolation and the recovery rate 
was higher than in the heat treatment procedure (data not 
shown). 
Protease (enterokinase) digestion was used to release ACTH- 
(1-24) from the fused protein. For this purpose two different 
buffer conditions were used, i.e. Tris-HC1 buffer at pH 8.0 and 
succinate buffer at pH 5.6. Fig. 2B shows the results of the 
digestion in the succinate buffer at pH 5.6 as analyzed by 
HPLC. Two main peaks and one minor peak were observed. 
Even though a highly purified enterokinase was used for this 
experiment, it contained trypsin contaminant. Consequently, 
peak 1 resulted from trypsin digestion. This was confirmed with 
Tris-HC1 buffer at pH 8.0 where peak 1 increased because 
trypsin activity is higher at pH 8.0 (data not shown). This 
biosynthetic material behaved identically to chemically synthe- 
sized material in amino acid analysis and chromatography. 
Finally, 15N-1H HSQC spectra (Fig. 3) were measured and 
compared with the amide-alpha proton region of 2D-NOESY 
spectra. Because the peptide contains 3Pro residues, 21 15N 1H 
cross-peaks were expected, but significantly more peaks were 
observed. This may be attributed to conformational equilibria 
involving cis trans isomerization of prolyl residues. Since the 
cross-peaks in the 2D-NOESY spectra of unlabeled ACTH-(1- 
24) were largely overlapping and thesensitivity of the NOESY 
spectra was significantly lower than that of the HSQC spectra 
as expected for peptides of this size, in fact, these additional 
cross-peaks could not be found in the homonuclear experi- 
ments. This shows the benefits of such an uniform labeling 
procedure in small peptides. Generally the intensities of NOE 
cross peaks are small for peptides with molecular weight in the 
range of 1000-5000. Because the sequece specific resonance 
assignment procedure of non-labeled peptides or proteins de- 
pends on NOESY spectra, it has been sometimes difficult to 
assign ~H resonances as well as to elucidate the structure of such 
peptides using interatomic distances derived from NOE intensi- 
ties. Once isotope labeling has been done, triple resonance 
experiments can be easily employed for making sequential 
Table 1 
The result of amino acid analysis a 
Amino Amount Normalized Predictided composi- 
acid (nmol) composition ~ tion from DNA 
Lys 8.839 3.80 4 
His 2.357 1.01 1 
Arg 7.055 3.04 3 
Ser 4.822 2.08 2 
Glu 2.425 1.04 1 
Pro 5.937 2.56 3 
Gly 5.158 2.22 2 
Val 6.691 2.88 3 
Met 2.269 0.98 1 
Tyr 4.643 2.00 2 
Phe 2.323 1.00 1 
"The amount of Trp was not determined. 
bThe calculated composition was normalized to Phe as one. 
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assignment of backbone atoms by means of well resolved 
heteronuclear one-bond and two-bond couplings. Further- 
more, secondary structure preferences can be derived directly 
from J-coupling constants and from chemical shift differences 
from the standard values without using NOE's (manuscript in 
preparation). Thus efficient over-expression systems as that 
described in this study may prove to be useful for obtaining 
more precise conformational informations on bioactive pep- 
tides in a variety of environments including those complexed 
with their receptors. 
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